Hepatitis C Virus Therapy
Research from University of Texas, Division of Gastroenterology provides new data on hepatitis C virus therapy
Published in Hepatitis Weekly, July 9th, 2007
A report, "The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C," is newly published data in Clinica Chimica Acta. "Multiple serum markers to estimate hepatic fibrosis in chronic liver disease have been proposed. The AST/Platelet Ratio Index (APRI) is a simple biochemical index that has been shown to be useful and accurate in about 50% of patients with chronic hepatitis C," scientists in the United States report.
"We determined if the combination of the APRI and the FIBROSpect II, a commercially available hepatic fibrosis marker that measures 3 components of the extracellular hepatic matrix, would further...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-07-09)
More Articles from Hepatitis Weekly
- HIV/AIDS
Needle-stick injuries are common but unreported by surgeons in training - Hepatitis
Genesis Dental Technologies, LLC Launches New Web Site Featuring the AquaSept Independent Water Delivery System to Prevent Disease Transmission in Dental Water - Hepatitis B Virus
Second Phase III Study Evaluating Gilead's Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint - Hepatitis C Virus
Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of the NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection - Hepatitis C Virus
Energex System's Experimental Non-Pharmacological Treatment Exceeds Expectations in Reducing Liver Inflammation in Refractory Hepatitis C Patients - Hepatitis C Virus
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
